Safety and efficacy of US-guided high-intensity focused ultrasound for treatment of submucosal fibroids

AbstractObjectivesTo evaluate the safety and efficacy of US-guided high-intensity focused ultrasound (HIFU) ablation for the treatment of submucosal fibroidsMethodsA total of 76 women with 78 submucosal uterine fibroids (68 type II fibroids, 10 type I fibroids) underwent US-guided HIFU ablation. The pretreatment fibroid diameter ranged from 2.4 to 13.5 cm (mean 5.7 ± 2.3 cm). The fibroids were ablated using a power output of 420–520 W. During follow-up, the volume shrinkage of the ablated fibroids was continuously observed on contrast-enhanced MR and/or contrast-enhanced ultrasound (CEUS). The change of symptoms was evaluated by using the symptom severity score questionnaire.ResultsHIFU ablation was well tolerated in all patients. No major complications occurred. The mean nonperfused ablation ratio was 80 ± 12 % on CEUS. During follow-up, the ablated fibroids shrank significantly over time. The symptoms were alleviated significantly. No patients had amenorrhoea after treatment. Vaginal expulsion of necrotic tissue was seen in 58 % (44/76) of patients after HIFU ablation which disappeared after 2–4 menstrual cycles. Four patients received repeated HIFU ablation for enlarged residual fibroids.ConclusionsUS-guided HIFU ablation may be a safe and effective treatment for submucosal fibroids. Further studies are warranted to observe its influence on fertility.Key points• High-intensity focused ultrasound (HIFU) is a new minimally invasive therapeutic technique. • HIFU ablation may be safe and effective for treatment of submucosal fibroids • Treatment is minimally invasive and repeatable. • Vaginal expulsion of necrotic tissue is common after treatment.

[1]  N. Niles,et al.  Renal cell carcinoma in pregnancy. , 1957, Obstetrics and gynecology.

[2]  B. Vollenhoven,et al.  Uterine fibroids: A clinical review , 1990, British journal of obstetrics and gynaecology.

[3]  K Wamsteker,et al.  Transcervical Hysteroscopic Resection of Submucous Fibroids for Abnormal Uterine Bleeding: Results Regarding the Degree of Intramural Extension , 1993, Obstetrics and gynecology.

[4]  P. Vercellini,et al.  The role of transvaginal ultrasonography and outpatient diagnostic hysteroscopy in the evaluation of patients with menorrhagia. , 1997, Human reproduction.

[5]  A. Hart,et al.  Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding. , 1999, Obstetrics and gynecology.

[6]  N. Bajekal,et al.  Fibroids, infertility and pregnancy wastage. , 2000, Human reproduction update.

[7]  Patrick E Sewell,et al.  Interventional magnetic resonance imaging cryotherapy of uterine fibroid tumors: preliminary observation. , 2002, American journal of obstetrics and gynecology.

[8]  D. Lamping,et al.  Clinical outcomes following percutaneous magnetic resonance image guided laser ablation of symptomatic uterine fibroids. , 2002, Human reproduction.

[9]  Mary Ann Lumsden,et al.  Embolization versus myomectomy versus hysterectomy: which is best, when? , 2002, Human reproduction.

[10]  K. Coyne,et al.  The UFS‐QOL, a New Disease‐Specific Symptom and Health‐Related Quality of Life Questionnaire for Leiomyomata , 2002, Obstetrics and gynecology.

[11]  Kullervo Hynynen,et al.  MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. , 2003, Radiology.

[12]  Matthias David,et al.  Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. , 2003, American journal of obstetrics and gynecology.

[13]  B. Hamm,et al.  Uterine fibroids: contrast-enhanced MR angiography to predict ovarian artery supply--initial experience. , 2006, Radiology.

[14]  F. Ghezzi,et al.  Percutaneous sonographically guided radiofrequency ablation of medium-sized fibroids: feasibility study. , 2007, AJR. American journal of roentgenology.

[15]  Min Zhang,et al.  Therapeutic response assessment of high intensity focused ultrasound therapy for uterine fibroid: utility of contrast-enhanced ultrasonography. , 2007, European journal of radiology.

[16]  S. Uzan,et al.  Long-term results of hysteroscopic myomectomy in 235 patients. , 2007, European journal of obstetrics, gynecology, and reproductive biology.

[17]  Gail ter Haar,et al.  High Intensity Focused Ultrasound: Past, present and future , 2007, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[18]  Gail ter Haar,et al.  Thermal ablation of uterine fibroids using MR-guided focused ultrasound-a truly non-invasive treatment modality , 2007, European Radiology.

[19]  W. Walker,et al.  Outcomes After Unilateral Uterine Artery Embolization: A Retrospective Review , 2008, CardioVascular and Interventional Radiology.

[20]  Li Li,et al.  Extracorporeal Ablation of Uterine Fibroids With High‐Intensity Focused Ultrasound , 2007, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[21]  W. Parker,et al.  Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. , 2007, Obstetrics and gynecology.

[22]  F. Ghezzi,et al.  Ultrasound-Guided Radiofrequency Thermal Ablation of Uterine Fibroids: Medium-Term Follow-Up , 2009, CardioVascular and Interventional Radiology.

[23]  S. LeBlang,et al.  Leiomyoma shrinkage after MRI-guided focused ultrasound treatment: report of 80 patients. , 2010, AJR. American journal of roentgenology.

[24]  H. Kauczor,et al.  Expulsion of dominant submucosal fibroids after uterine artery embolization. , 2010, European journal of radiology.